Tazia Ann Cook, OD - Medicare Optometrist in Yukon, OK

Tazia Ann Cook, OD is a medicare enrolled "Optometrist" provider in Yukon, Oklahoma. She graduated from medical school in 2017 and has 7 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Eye Care Associates Of Yukon and her current practice location is 1604 Professional Cir, Yukon, Oklahoma. You can reach out to her office (for appointments etc.) via phone at (405) 354-3624.

Tazia Ann Cook is licensed to practice in Oklahoma (license number OK2921) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1750804134.

Contact Information

Tazia Ann Cook, OD
1604 Professional Cir,
Yukon, OK 73099-6314
(405) 354-3624
(405) 350-7512



Healthcare Provider's Profile

Full NameTazia Ann Cook
GenderFemale
SpecialityOptometry
Experience7 Years
Location1604 Professional Cir, Yukon, Oklahoma
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Tazia Ann Cook graduated from medical school in 2017
  NPI Data:
  • NPI Number: 1750804134
  • Provider Enumeration Date: 07/18/2017
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4486928306
  • Enrollment ID: I20170915001831

Medical Identifiers

Medical identifiers for Tazia Ann Cook such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1750804134NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist OK2921 (Oklahoma)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Eye Care Associates Of Yukon12544925722

News Archive

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

FDA approves revised clinical trial protocol for CytRx' arimoclomol

CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

AMAG receives Health Canada Notice of Non-Compliance for Feraheme NDS

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tazia Ann Cook allows following entities to bill medicare on her behalf.
Provider NameEye Care Associates Of Yukon
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1831318633
PECOS PAC ID: 1254492572
Enrollment ID: O20081205000068

News Archive

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

FDA approves revised clinical trial protocol for CytRx' arimoclomol

CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

AMAG receives Health Canada Notice of Non-Compliance for Feraheme NDS

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tazia Ann Cook is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Tazia Ann Cook, OD
1604 Professional Cir,
Yukon, OK 73099-6314

Ph: (405) 354-3624
Tazia Ann Cook, OD
1604 Professional Cir,
Yukon, OK 73099-6314

Ph: (405) 354-3624

News Archive

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

FDA approves revised clinical trial protocol for CytRx' arimoclomol

CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), following the U.S. Food and Drug Administration's (FDA) acceptance of a revised clinical trial protocol.

Combination of anti-Nodal and DTIC therapy can produce anti-cancer effects

Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

AMAG receives Health Canada Notice of Non-Compliance for Feraheme NDS

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has received a Notice of Non-Compliance (NON) from Health Canada regarding its New Drug Submission (NDS) for Feraheme® (ferumoxytol) injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

Read more News

› Verified 8 days ago


Optometrist in Yukon, OK

Oklahoma Eye Specialist Pllc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2001 Wheatfield Ave, Yukon, OK 73099
Phone: 405-308-3430    
Michael Joseph Hampton, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1604 Professional Cir, Yukon, OK 73099
Phone: 405-354-3624    Fax: 405-350-7512
Total Optical Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 4400 Grant Blvd, Suite 106, Yukon, OK 73099
Phone: 405-603-4744    
Legacy Eye Care Pllc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1207 Cornwell Dr, Yukon, OK 73099
Phone: 405-354-3384    
Dr. John Mace, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: Ultimate Vision, 334 S. Mustang Rd, Yukon, OK 73099
Phone: 405-324-0001    Fax: 405-324-0015
Dr. Valerie Ridgena Hatley, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 621 W Main St, Yukon, OK 73099
Phone: 405-354-2788    
Dr. David Charles Brewer, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1207 S Cornwell Dr, Yukon, OK 73099
Phone: 405-354-3384    Fax: 405-354-0703

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.